Recent clinical trials with stem cells to slow or reverse normal aging processes

Area of Science:

• Gerontology and Regenerative Medicine
• Stem Cell Biology and Therapeutics

Background:

• Aging diminishes stem cell regenerative capacity, prompting research into stem cell interventions.
• Mesenchymal stem cell (MSC) therapies are being investigated to combat age-related conditions.
• Clinical trials are evaluating MSC efficacy for physical frailty and facial skin aging.

Purpose of the Study:

• To review current clinical trials on mesenchymal stem cell interventions for aging conditions.
• To assess the efficacy and safety of MSCs in treating physical frailty and facial skin aging.
• To understand the complementary nature of research in these two aging areas.

Main Methods:

• Systematic extraction of data from national and international clinical trial databases (US, EU, China, Japan, WHO).
• Analysis of ongoing and completed clinical trials for physical frailty and facial skin aging.
• Review of reported outcomes for specific MSC preparations (Lomecel-B, umbilical cord-derived MSCs, adipose-derived MSCs).

Main Results:

• Positive phase II results for intravenous Lomecel-B in physical frailty.
• Completion of a phase I/II study for umbilical cord-derived MSCs in physical frailty.
• Positive results for autologous adipose-derived stem cells in facial skin aging.
• Sixteen additional clinical trials are currently active for these conditions.

Conclusions:

• Mesenchymal stem cell interventions show potential for improving healthy life expectancy and public health outcomes in physical frailty.
• Research into facial skin aging using MSCs offers insights into tissue regeneration.
• Investigating both physical frailty and skin aging provides a comprehensive view of MSC therapeutic potential in aging.